Literature DB >> 15925886

High distress in parents whose children undergo predictive testing for long QT syndrome.

Karin S W H Hendriks1, F J M Grosfeld, A A M Wilde, J van den Bout, I M van Langen, J P van Tintelen, H F J ten Kroode.   

Abstract

OBJECTIVES: To assess the psychological effect of predictive testing in parents of children at risk for long QT syndrome (LQTS) in a prospective study.
METHODS: After their child was clinically screened by electrocardiography and blood was taken for DNA analysis, and shortly after delivery of the DNA test result, 36 parents completed measures of psychological distress.
RESULTS: 24 parents were informed that at least one of their children is a mutation carrier. Up to 50% of the parents of carrier children showed clinically relevant high levels of distress. Parents who were familiar with the disease for a longer time, who had more experiences with the disease in their family and who received positive test results for all their children were most distressed.
CONCLUSIONS: Predictive ECG testing together with DNA testing has a profound impact on parents whose minors undergo predictive testing for LQTS. Copyright 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2005        PMID: 15925886     DOI: 10.1159/000084778

Source DB:  PubMed          Journal:  Community Genet        ISSN: 1422-2795


  10 in total

1.  [Genetic testing in hereditary arrythmia syndromes today and in the future].

Authors:  Britt-Maria Beckmann; Stefan Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2012-09-20

2.  LQTS parents' reflections about genetic risk knowledge and their need to know or not to know their children's carrier status.

Authors:  Margrete Mangset; Bjørn Hofmann
Journal:  J Genet Couns       Date:  2014-05-01       Impact factor: 2.537

3.  Predictors of heart-focused anxiety in patients undergoing genetic investigation and counseling of long QT syndrome or hypertrophic cardiomyopathy: a one year follow-up.

Authors:  Anniken Hamang; Geir Egil Eide; Berit Rokne; Karin Nordin; Cathrine Bjorvatn; Nina Øyen
Journal:  J Genet Couns       Date:  2011-07-20       Impact factor: 2.537

4.  Living with long QT syndrome: a qualitative study of coping with increased risk of sudden cardiac death.

Authors:  Janice Andersen; Nina Øyen; Cathrine Bjorvatn; Eva Gjengedal
Journal:  J Genet Couns       Date:  2008-08-22       Impact factor: 2.537

5.  Pre-symptomatic genetic testing for inherited cardiac conditions: a qualitative exploration of psychosocial and ethical implications.

Authors:  Elizabeth Ormondroyd; Stephanie Oates; Michael Parker; Edward Blair; Hugh Watkins
Journal:  Eur J Hum Genet       Date:  2013-05-01       Impact factor: 4.246

6.  General anxiety, depression, and physical health in relation to symptoms of heart-focused anxiety- a cross sectional study among patients living with the risk of serious arrhythmias and sudden cardiac death.

Authors:  Anniken Hamang; Geir E Eide; Berit Rokne; Karin Nordin; Nina Øyen
Journal:  Health Qual Life Outcomes       Date:  2011-11-14       Impact factor: 3.186

Review 7.  A Person-Centered Approach to Cardiovascular Genetic Testing.

Authors:  Julia Platt
Journal:  Cold Spring Harb Perspect Med       Date:  2020-07-01       Impact factor: 5.159

8.  The role of the epinephrine test in the diagnosis and management of children suspected of having congenital long QT syndrome.

Authors:  Sally-Ann B Clur; Priya Chockalingam; Luc H Filippini; Ari P Widyanti; Marc Van Cruijsen; Nico A Blom; Mariel Alders; Nynke Hofman; Arthur A M Wilde
Journal:  Pediatr Cardiol       Date:  2009-12-03       Impact factor: 1.655

9.  Health status in patients at risk of inherited arrhythmias and sudden unexpected death compared to the general population.

Authors:  Anniken Hamang; Geir Egil Eide; Karin Nordin; Berit Rokne; Cathrine Bjorvatn; Nina Øyen
Journal:  BMC Med Genet       Date:  2010-02-17       Impact factor: 2.103

10.  Brain and behavior development in autism from birth through infancy.

Authors:  Mark D Shen; Joseph Piven
Journal:  Dialogues Clin Neurosci       Date:  2017-12       Impact factor: 5.986

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.